-
Product Insights
Graves' Ophthalmopathy - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Graves' Ophthalmopathy - Global Clinical Trials Review, H2, 2021" provides an overview of Graves' Ophthalmopathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Graves' Ophthalmopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Myopia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myopia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Bacterial Keratitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bacterial Keratitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Choroideremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Choroideremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Choroideremia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Choroideremia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Infectious Endophthalmitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Infectious Endophthalmitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Keratoconjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Keratoconjunctivitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Conjunctivitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Intermediate Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Intermediate Uveitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Fuchs Endothelial Corneal Dystrophy (FECD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Fuchs Endothelial Corneal Dystrophy (FECD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Fuchs Endothelial Corneal Dystrophy (FECD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fuchs Endothelial Corneal Dystrophy (FECD), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Herpetic Keratitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Herpetic Keratitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.